Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Quick Stats
Jan 30, 202656.0
AI Score
HOLD1.38
Volume Ratio
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
ELTX Stock Summary
Last updated Jan 30, 2026
ELTX is currently trading at $7.6, positioned below its 200-day moving average of $8.61, suggesting bearish momentum. The stock has a 52-week range of $4.6 to $12.62.
Technical Analysis: The 50-day moving average stands at $8.18, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.895, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.202, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ELTX at 56.0/100 with a HOLD recommendation.
ELTX (Elicio Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.895 |
| CMF (20) | -0.202 |
| ROC (10) | -2.689 |
| ADX (14) | 22.871 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.051 |
| AROONOSC (14) | -64.286 |
| WILLAMS %R (14) | -85.89 |
| MFI (14) | 57.573 |
ELTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ELTX Price vs Max Options Open Interest
ELTX Max Change In Options Open Interest
ELTX Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ELTX Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ELTX Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ELTX Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Elicio Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ELTX Moving Averages Analysis
ELTX (Elicio Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 8.07 |
| 20 | 8.03 |
| 30 | 8.02 |
| 50 | 8.18 |
| 100 | 9.21 |
| 200 | 8.61 |
ELTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 139.4 million |
| Earnings/Share ($) | -3.11 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.505 |
| EPS Estimate Next Year ($) | -1.505 |
| WallStreet Target Price ($) | 15.5 |
| Most Recent Quarter |